Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Jost, Philipp J
[Clear All Filters]
2020
Schwaab J
,
Naumann N
,
Luebke J
,
Jawhar M
,
Somervaille TCP
,
Williams MS
,
Frewin R
,
Jost PJ
,
Lichtenegger FS
,
La Rosée P
, et al.
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
Am J Hematol. 2020.
PubMed
Google Scholar
2021
Kricheldorf K
,
Döhner K
,
Stegelmann F
,
Jost PJ
,
Lang F
,
Radsak M
,
Hansen R
,
Heuer V
,
Röhrig R
,
Brümmendorf TH
, et al.
Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: First results from a patient survey by the German Study Group for MPN.
Leuk Res. 2021;110:106646.
PubMed
Google Scholar
2022
Koschmieder S
,
Isfort S
,
Wolf D
,
Heidel FH
,
Hochhaus A
,
Schafhausen P
,
Griesshammer M
,
Wolleschak D
,
Platzbecker U
,
Döhner K
, et al.
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
Ann Hematol. 2022.
PubMed
Google Scholar
Heilig CE
,
Laßmann A
,
Mughal SS
,
Mock A
,
Pirmann S
,
Teleanu V
,
Renner M
,
Andresen C
,
Köhler BC
,
Aybey B
, et al.
Gene expression-based prediction of pazopanib efficacy in sarcoma.
Eur J Cancer. 2022;172:107-118.
PubMed
Google Scholar